✦ LIBER ✦

Benefit of the Addition of Paclitaxel to Standard Chemotherapy with 5-Fluorouracil/Doxorubicin/Cyclophosphamide in Patients with Operable Breast Cancer

Book ID: 119615099
Publisher: CIG Media Group, LP.
Year: 2000
Tongue: English
Weight: 80 KB
Volume: 1
Category: Article
ISSN: 1526-8209
DOI: 10.1016/s1526-8209(11)70133-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomic Predictor of Sensitivity

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Hess, K. R.; Anderson, K.; Symmans, W. F.; Valero, V.; Ibrahim, N.; Mejia, J. A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 362 KB

Pharmacogenomic Predictor of Sensitivity

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

✍ Hayes, D.F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Prospective randomized trial of 5-fluoro

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

✍ Jeffrey M. Albert; Aman U. Buzdar; Reina Guzman; Pamela K. Allen; Eric A. Strom; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 240 KB

Neoadjuvant chemotherapy with cyclophosp

Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer

✍ Pankaj Gupta; Loveleen Bilani; Gaur K. Rath; Anoop Misra; Mahesh C. Mishra; Nuta 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 340 KB

Quality of life and toxicity in breast c

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

✍ N. Hatam; N. Ahmadloo; A. Ahmad Kia Daliri; P. Bastani; M. Askarian 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

The addition of bevacizumab to standard

The addition of bevacizumab to standard chemotherapy in breast cancer: which patient benefits the most?

✍ Vibeke Kruse, Hannelore Denys, Rudy Van Den Broecke, Simon Van Belle… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 181 KB